Skip to main content

Adipocyte-Specific Deficiency of NADPH Oxidase 4 Delays the Onset of Insulin Resistance and Attenuates Adipose Tissue Inflammation in Obesity.

Citation
Hartigh, L. J. den, et al. “Adipocyte-Specific Deficiency Of Nadph Oxidase 4 Delays The Onset Of Insulin Resistance And Attenuates Adipose Tissue Inflammation In Obesity.”. Arteriosclerosis, Thrombosis, And Vascular Biology, pp. 466-475.
Center University of Washington
Author Laura J den Hartigh, Mohamed Omer, Leela Goodspeed, Shari Wang, Tomasz Wietecha, Kevin D O'Brien, Chang Yeop Han
Keywords NADPH oxidase, adipocyte, Insulin resistance, obesity, reactive oxygen species
Abstract

OBJECTIVE: Obesity is associated with insulin resistance and adipose tissue inflammation. Reactive oxygen species (ROS) increase in adipose tissue during the development of obesity. We previously showed that in response to excess nutrients like glucose and palmitate, adipocytes generated ROS via NADPH oxidase (NOX) 4, the major adipocyte isoform, instead of using mitochondrial oxidation. However, the role of NOX4-derived ROS in the development of whole body insulin resistance, adipocyte inflammation, and recruitment of macrophages to adipose tissue during the development of obesity is unknown.

APPROACH AND RESULTS: In this study, control C57BL/6 mice and mice in which NOX4 has been deleted specifically in adipocytes were fed a high-fat, high-sucrose diet. During the development of obesity in control mice, adipocyte NOX4 and pentose phosphate pathway activity were transiently increased. Primary adipocytes differentiated from mice with adipocytes deficient in NOX4 showed resistance against high glucose or palmitate-induced adipocyte inflammation. Mice with adipocytes deficient in NOX4 showed a delayed onset of insulin resistance during the development of obesity, with an initial reduction in adipose tissue inflammation that normalized with prolonged high-fat, high-sucrose feeding.

CONCLUSIONS: These findings imply that NOX4-derived ROS may play a role in the onset of insulin resistance and adipose tissue inflammation. As such, therapeutics targeting NOX4-mediated ROS production could be effective in preventing obesity-associated conditions, such as insulin resistance.

Year of Publication
2017
Journal
Arteriosclerosis, thrombosis, and vascular biology
Volume
37
Issue
3
Number of Pages
466-475
Date Published
03/2017
ISSN Number
1524-4636
DOI
10.1161/ATVBAHA.116.308749
Alternate Journal
Arterioscler. Thromb. Vasc. Biol.
PMID
28062496
PMCID
PMC5323321
Download citation